Hui Huang

1.7k total citations
97 papers, 1.1k citations indexed

About

Hui Huang is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Hui Huang has authored 97 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pulmonary and Respiratory Medicine, 25 papers in Epidemiology and 14 papers in Surgery. Recurrent topics in Hui Huang's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (46 papers), Medical Imaging and Pathology Studies (15 papers) and Lung Cancer Treatments and Mutations (10 papers). Hui Huang is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (46 papers), Medical Imaging and Pathology Studies (15 papers) and Lung Cancer Treatments and Mutations (10 papers). Hui Huang collaborates with scholars based in China, United Kingdom and United States. Hui Huang's co-authors include Zuojun Xu, Chunguo Jiang, Zhiwei Lu, Yanxun Wang, Zuo Jun Xu, Kai Xu, Xiaoyan Jing, Jian Guo, Jing He Lang and Lin Qiu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Agricultural and Food Chemistry.

In The Last Decade

Hui Huang

89 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui Huang China 19 480 192 187 155 153 97 1.1k
Sun‐Young Jun South Korea 22 564 1.2× 392 2.0× 236 1.3× 75 0.5× 462 3.0× 98 1.6k
Lan Li China 16 293 0.6× 482 2.5× 70 0.4× 43 0.3× 227 1.5× 51 1.2k
Ayşe Dursun Türkiye 21 214 0.4× 228 1.2× 139 0.7× 71 0.5× 274 1.8× 82 1.2k
Konstantinos Savvatis Germany 23 86 0.2× 366 1.9× 113 0.6× 67 0.4× 101 0.7× 31 1.4k
Luiz Stark Aroeira Spain 23 218 0.5× 376 2.0× 130 0.7× 99 0.6× 150 1.0× 44 1.9k
Alexandra C. Racanelli United States 10 334 0.7× 452 2.4× 274 1.5× 85 0.5× 139 0.9× 18 1.1k
Shun‐Chen Huang Taiwan 17 168 0.3× 186 1.0× 85 0.5× 72 0.5× 142 0.9× 80 940
Álvaro Martínez United States 16 286 0.6× 82 0.4× 57 0.3× 29 0.2× 96 0.6× 43 917
Hourong Cai China 22 661 1.4× 399 2.1× 236 1.3× 236 1.5× 121 0.8× 51 1.3k
Issam M. Francis Kuwait 19 108 0.2× 146 0.8× 105 0.6× 29 0.2× 218 1.4× 55 1.0k

Countries citing papers authored by Hui Huang

Since Specialization
Citations

This map shows the geographic impact of Hui Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Huang more than expected).

Fields of papers citing papers by Hui Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Huang. The network helps show where Hui Huang may publish in the future.

Co-authorship network of co-authors of Hui Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Huang. A scholar is included among the top collaborators of Hui Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Huang. Hui Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Xinzhuang, Yu Chen, Xiuling Zhang, et al.. (2025). The Prospective Registry of MyositIS (PROMIS): I. Next-generation sequencing identifies HLA-DQA1 as a novel genetic risk of anti-MDA5 antibody-positive dermatomyositis. Annals of the Rheumatic Diseases. 84(7). 1221–1230.
2.
Tong, Jiayi, Hui Huang, Peiyu Li, et al.. (2025). Enabling inclusive systematic reviews: incorporating preprint articles with large language model-driven evaluations. Journal of the American Medical Informatics Association. 32(11). 1718–1725.
3.
Zhang, Zhendong, et al.. (2025). Systematic Review and Meta-Analysis of Risk Factors Associated with Postoperative Stress Hyperglycemia in Patients without Diabetes Following Cardiac Surgery. Reviews in Cardiovascular Medicine. 26(1). 25485–25485. 1 indexed citations
4.
Yan, Yawei, et al.. (2024). Erianin alleviates LPS-induced acute lung injury via antagonizing P-selectin-mediated neutrophil adhesion function. Journal of Ethnopharmacology. 331. 118336–118336. 6 indexed citations
5.
Huang, Hui, et al.. (2024). The Clinical Analysis of Checkpoint Inhibitor Pneumonitis with Different Severities in Lung Cancer Patients: A Retrospective Study. Journal of Clinical Medicine. 13(1). 255–255. 3 indexed citations
6.
Wang, Ping, et al.. (2024). Differences Between Patients with Probable UIP and Definite UIP on HRCT in Idiopathic Pulmonary Fibrosis: A Real-World Cohort Study. Journal of Clinical Medicine. 13(23). 7170–7170. 1 indexed citations
7.
Chen, Ruxuan, et al.. (2024). Prognostic analysis of concurrent Pneumocystis jirovecii pneumonia in patients with systemic lupus erythematosus: a retrospective study. BMC Infectious Diseases. 24(1). 874–874. 1 indexed citations
8.
Li, Runzhi, Jiwei Jiang, Linlin Wang, et al.. (2024). Neuroimaging analysis reveals distinct cerebral perfusion responses to fasting‐postprandial metabolic switching in Alzheimer's disease patients. CNS Neuroscience & Therapeutics. 30(9). e70014–e70014. 2 indexed citations
9.
Sun, Wei, Xiaoyu Yang, Lijuan Chen, et al.. (2023). FSTL1 promotes alveolar epithelial cell aging and worsens pulmonary fibrosis by affecting SENP1‐mediated DeSUMOylation. Cell Biology International. 47(10). 1716–1727. 10 indexed citations
10.
11.
Huang, Hui, Yan Diao, Bowei Liu, et al.. (2023). Identification of biomarkers associated with immune-propionate metabolism in nonalcoholic fatty liver disease. Cellular and Molecular Biology. 69(10). 254–263. 1 indexed citations
12.
Gao, Shaoyan, Xiaohe Li, Ting Xiao, et al.. (2022). PKM2 promotes pulmonary fibrosis by stabilizing TGF-β1 receptor I and enhancing TGF-β1 signaling. Science Advances. 8(38). eabo0987–eabo0987. 60 indexed citations
13.
Ruan, Si‐Min, Hui Huang, Manxia Lin, et al.. (2022). Shear-wave elastography combined with contrast-enhanced ultrasound algorithm for noninvasive characterization of focal liver lesions. La radiologia medica. 128(1). 6–15. 13 indexed citations
14.
Liu, Tao, Xiaotong Zhang, Xiaoyan Si, et al.. (2020). Opportunistic infections complicating immunotherapy for non‐small cell lung cancer. Thoracic Cancer. 11(6). 1689–1694. 15 indexed citations
15.
Li, Shan, Yongzhe Liu, Hui Huang, et al.. (2019). [The role of histone deacetylases in the pathogenesis of idiopathic pulmonary fibrosis and cryptogenic organizing pneumonia].. PubMed. 42(5). 361–366. 1 indexed citations
16.
Huang, Hui, et al.. (2015). Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients. Medicine. 94(42). e1600–e1600. 30 indexed citations
17.
Zhao, Yuyue, Hui Huang, Yongzhe Liu, et al.. (2015). Whole Lung Lavage Treatment of Chinese Patients with Autoimmune Pulmonary Alveolar Proteinosis. Chinese Medical Journal. 128(20). 2714–2719. 16 indexed citations
18.
Huang, Hui, Yanxun Wang, Chunguo Jiang, et al.. (2013). Intrapulmonary concentration of levofloxacin in patients with idiopathic pulmonary fibrosis. Pulmonary Pharmacology & Therapeutics. 28(1). 49–52. 10 indexed citations
19.
Huang, Hui, Marianne Su‐Ling Brooks, Hua Huang, & Xiao Dong Chen. (2009). Inactivation Kinetics of Yeast Cells during Infrared Drying. Drying Technology. 27(10). 1060–1068. 16 indexed citations
20.
Zhang, Ning, Yi Huan, Hui Huang, et al.. (2009). Atorvastatin improves insulin sensitivity in mice with obesity induced by monosodium glutamate. Acta Pharmacologica Sinica. 31(1). 35–42. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sun‐Young Jun Breakdown of academic impact, for papers by Lan Li Breakdown of academic impact, for papers by Ayşe Dursun Breakdown of academic impact, for papers by Konstantinos Savvatis Breakdown of academic impact, for papers by Luiz Stark Aroeira Breakdown of academic impact, for papers by Alexandra C. Racanelli Breakdown of academic impact, for papers by Shun‐Chen Huang Breakdown of academic impact, for papers by Álvaro Martínez Breakdown of academic impact, for papers by Hourong Cai Breakdown of academic impact, for papers by Issam M. Francis
Rankless by CCL
2026